9月1日起,北京市将国家药品目录新增的477种药品和国家组织谈判的36种药品共513种,全部纳入本市医保报销范围,进一步方便群众就医用药。其中36种谈判药品,大部分曾是需长期门诊治疗、费用较高、患者普遍反映负担较重的药品。据测算,此次门诊特殊病政策调整将为大病患者每年 Since September 1, Beijing has added a total of 513 kinds of 47 kinds of drugs newly negotiated from the state drug list and 36 kinds of drugs negotiated by the state organizations, all of which will be included in the reimbursement of medical insurance in this Municipality to further facilitate medical treatment of the masses. Of the 36 negotiated drugs, most of them required long-term outpatient treatment at a higher cost. Patients generally reflected the heavier burden of medicines. It is estimated that the outpatient special disease policy adjustment will be seriously ill patients each year